Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

15
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Viral Meningitis01:18

Viral Meningitis

199
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

21
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
21
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

24
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurosurgeons' perspective on surgical treatment of glioblastoma: Practices, beliefs and willingness to randomize in surgical trials.

Neuro-oncology advances·2026
Same author

Microstructure-informed biphasic-osmotic modeling of intervertebral disc degeneration.

Biomechanics and modeling in mechanobiology·2026
Same author

The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.

Neuro-oncology·2026
Same author

Intratumoral hemorrhage in patients with brain metastasis from systemic tumors: risk factors and prognostic assessment.

Journal of neuro-oncology·2026
Same author

Clinical Implementation and Oncological Relevance of Molecular Profiling in Brain Metastases Patients-A Multicenter Retrospective Cohort Study.

International journal of cancer·2026
Same author

BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Society for Neuro-Oncology (EANO) consensus review on clinical management and future directions.

Neuro-oncology·2026

Related Experiment Video

Updated: May 2, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
07:14

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

1.9K

[Leptomeningeal metastases from solid tumors].

Emilie Le Rhun, Fahed Zairi, Thomas Boulanger

    La Revue Du Praticien
    |March 22, 2014
    PubMed
    Summary

    Leptomeningeal metastases are increasingly diagnosed in cancer patients. Early, multidisciplinary treatment significantly improves quality of life and prolongs survival.

    Area of Science:

    • Oncology
    • Neurology
    • Cancer Research

    Context:

    • Increasing incidence of leptomeningeal metastases due to improved cancer patient survival.
    • Challenges in early diagnosis of leptomeningeal carcinomatosis.
    • Critical need for prompt intervention before neurological deficits arise.

    Purpose:

    • To highlight the growing challenge of leptomeningeal metastases.
    • To emphasize the importance of early diagnosis and treatment.
    • To outline current therapeutic strategies and management approaches.

    Summary:

    • Leptomeningeal metastases (leptomeningeal carcinomatosis) are increasingly detected in cancer patients with improved survival rates.
    • Untreated patients have a median survival of 4-6 weeks; specific treatments can extend this by months.

    More Related Videos

    A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
    07:17

    A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

    Published on: January 29, 2021

    7.6K
    Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
    07:42

    Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection

    Published on: January 16, 2026

    325

    Related Experiment Videos

    Last Updated: May 2, 2026

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
    07:14

    Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

    Published on: May 23, 2025

    1.9K
    A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
    07:17

    A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

    Published on: January 29, 2021

    7.6K
    Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
    07:42

    Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection

    Published on: January 16, 2026

    325
  • Treatment involves a multimodal approach including chemotherapy, targeted therapies, surgery, and radiotherapy, tailored to individual patient and disease characteristics.
  • Impact:

    • Early treatment of leptomeningeal metastases is crucial for improving patient quality of life.
    • Multidisciplinary management optimizes patient outcomes for leptomeningeal disease.
    • Advances in cancer care necessitate specialized approaches for leptomeningeal metastases.